On March 12, 2019 Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, reported that the Company will present at the following upcoming investor conferences (Press release, Verastem, MAR 12, 2019, View Source;p=RssLanding&cat=news&id=2390946 [SID1234534265]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The 31st Annual ROTH Conference on Tuesday, March 19, 2019 at 12:00pm PDT in Dana Point, CA, USA
The Oppenheimer 29th Annual Healthcare Conference on Tuesday, March 19, 2019 at 11:30am EDT in New York City, NY, USA
A live webcast of these presentations will be available on the investors section of the Company’s website at www.verastem.com. An archived presentation will be available for 90 days.